Erratum to: A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure
Massarweh, Suleiman, Romond, Edward, Black, Esther P., Van Meter, Emily, Shelton, Brent, Kadamyan-Melkumian, Vera, Stevens, Mark, Elledge, RichardVolume:
149
Language:
english
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-015-3263-0
Date:
January, 2015
File:
PDF, 107 KB
english, 2015